ROC-话题@MedSci - 梅斯（MedSci）

#ROC#

194篇内容 | 4383人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1977029, encodeId=bb2e19e702914, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Int Immunopharmacol：Crocin通过调节巨噬细胞极化，抑制钛粒子诱导的炎症，促进种植体周围炎的再成骨, objectType=article, longId=201815, objectId=4ecb2018151e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ecb2018151e, replyNumber=0, likeNumber=104, createdTime=2021-06-19, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ecb2018151e, moduleTitle=Int Immunopharmacol：Crocin通过调节巨噬细胞极化，抑制钛粒子诱导的炎症，促进种植体周围炎的再成骨, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ecb2018151e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977025, encodeId=883e19e7025f0, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Ann Noninvasive Electrocardiol：继发性房颤更危险！中国注册研究, objectType=article, longId=198305, objectId=93e1198305ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93e1198305ee, replyNumber=0, likeNumber=73, createdTime=2021-03-01, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93e1198305ee, moduleTitle=Ann Noninvasive Electrocardiol：继发性房颤更危险！中国注册研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93e1198305ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977032, encodeId=994919e70321c, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, objectType=article, longId=206733, objectId=aed0206e3371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed0206e3371, replyNumber=0, likeNumber=78, createdTime=2021-02-04, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed0206e3371, moduleTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aed0206e3371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977028, encodeId=84df19e7028f0, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=疾病风险预测模型评价方法：ROC曲线，拟合优度检验与NRI, objectType=article, longId=200807, objectId=006f20080e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=006f20080e69, replyNumber=0, likeNumber=85, createdTime=2021-02-28, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=006f20080e69, moduleTitle=疾病风险预测模型评价方法：ROC曲线，拟合优度检验与NRI, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=006f20080e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977026, encodeId=ebd219e702690, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性, objectType=article, longId=199169, objectId=79d81991691e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79d81991691e, replyNumber=0, likeNumber=99, createdTime=2021-04-03, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79d81991691e, moduleTitle=Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79d81991691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977019, encodeId=a85319e7019cb, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Neurocrit Care：腰穿引起的出血性休克, objectType=article, longId=188326, objectId=c7b818832672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7b818832672, replyNumber=0, likeNumber=75, createdTime=2020-05-18, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7b818832672, moduleTitle=Neurocrit Care：腰穿引起的出血性休克, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c7b818832672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977020, encodeId=956c19e702038, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Circulation：高PRS的CAD患者可从alirocumab治疗中明显获益, objectType=article, longId=189139, objectId=6dd118913900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dd118913900, replyNumber=0, likeNumber=104, createdTime=2020-04-28, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dd118913900, moduleTitle=Circulation：高PRS的CAD患者可从alirocumab治疗中明显获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6dd118913900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977027, encodeId=aff019e702732, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Proc Natl Acad Sci U S A：与成年人不同，儿童使用两个大脑半球来理解执行语言功能, objectType=article, longId=200738, objectId=4e07200e38a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e07200e38a8, replyNumber=0, likeNumber=92, createdTime=2020-12-08, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e07200e38a8, moduleTitle=Proc Natl Acad Sci U S A：与成年人不同，儿童使用两个大脑半球来理解执行语言功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e07200e38a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977023, encodeId=4fbb19e702387, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Eur Heart J：Alirocumab 对高龄冠心病患者预后的影响研究, objectType=article, longId=196733, objectId=d89c196e3356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89c196e3356, replyNumber=0, likeNumber=91, createdTime=2020-08-17, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89c196e3356, moduleTitle=Eur Heart J：Alirocumab 对高龄冠心病患者预后的影响研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d89c196e3356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977015, encodeId=f2e419e70154a, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Endod：重复使用Reciproc Blue在根管再治疗中的循环疲劳强度, objectType=article, longId=184641, objectId=438e18464121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438e18464121, replyNumber=0, likeNumber=71, createdTime=2020-04-28, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438e18464121, moduleTitle=J Endod：重复使用Reciproc Blue在根管再治疗中的循环疲劳强度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=438e18464121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977017, encodeId=4d5719e7017ad, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Endod：Reciproc和Reciproc Blue系统对弯曲根管再治疗的性能比较, objectType=article, longId=185704, objectId=825f185e04da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=825f185e04da, replyNumber=0, likeNumber=91, createdTime=2020-07-16, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=825f185e04da, moduleTitle=J Endod：Reciproc和Reciproc Blue系统对弯曲根管再治疗的性能比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=825f185e04da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977022, encodeId=2ddc19e702224, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Endod：3种Reciprocating单支锉NiTi系统在单/双弯曲根管内的成形能力评估, objectType=article, longId=195787, objectId=a436195e87d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a436195e87d0, replyNumber=0, likeNumber=74, createdTime=2021-05-19, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a436195e87d0, moduleTitle=J Endod：3种Reciprocating单支锉NiTi系统在单/双弯曲根管内的成形能力评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a436195e87d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977021, encodeId=acde19e702121, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=III期JADE Compare试验：JAK1抑制剂abrocitinib治疗特应性皮炎取得积极结果, objectType=article, longId=190430, objectId=bffb1904303e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bffb1904303e, replyNumber=0, likeNumber=86, createdTime=2020-12-30, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bffb1904303e, moduleTitle=III期JADE Compare试验：JAK1抑制剂abrocitinib治疗特应性皮炎取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bffb1904303e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977024, encodeId=b68219e7024dc, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Lancet：abrocitinib单药用于中重度特应性皮炎的治疗, objectType=article, longId=198029, objectId=d78c19802962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d78c19802962, replyNumber=0, likeNumber=80, createdTime=2021-06-01, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d78c19802962, moduleTitle=Lancet：abrocitinib单药用于中重度特应性皮炎的治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d78c19802962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977013, encodeId=eb1b19e70131f, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=EMUC19：Liproca®Depot治疗前列腺癌的IIb期研究达到了主要和次要终点, objectType=article, longId=183159, objectId=09e2183159c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e2183159c2, replyNumber=0, likeNumber=87, createdTime=2020-04-05, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e2183159c2, moduleTitle=EMUC19：Liproca®Depot治疗前列腺癌的IIb期研究达到了主要和次要终点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09e2183159c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977010, encodeId=f6a719e701051, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Cefiderocol在治疗院内肺炎方面不逊于大剂量的美罗培南, objectType=article, longId=180594, objectId=f3c3180594c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3c3180594c7, replyNumber=0, likeNumber=90, createdTime=2019-10-19, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3c3180594c7, moduleTitle=Cefiderocol在治疗院内肺炎方面不逊于大剂量的美罗培南, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3c3180594c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977011, encodeId=428919e7011c9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Clin Chem：控制大麻吸入后Δ9-Tetrahydrocannabinol浓度和释放动力学的相关性, objectType=article, longId=181617, objectId=8fd018161e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fd018161e74, replyNumber=0, likeNumber=87, createdTime=2020-07-29, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fd018161e74, moduleTitle=Clin Chem：控制大麻吸入后Δ9-Tetrahydrocannabinol浓度和释放动力学的相关性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8fd018161e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977006, encodeId=fe4119e7006fe, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=机器学习：准确率(Precision)、召回率(Recall)、F值(F-Measure)、ROC曲线、PR曲线, objectType=article, longId=175487, objectId=75cf1e54877d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75cf1e54877d, replyNumber=0, likeNumber=87, createdTime=2020-03-04, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75cf1e54877d, moduleTitle=机器学习：准确率(Precision)、召回率(Recall)、F值(F-Measure)、ROC曲线、PR曲线, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=75cf1e54877d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977002, encodeId=c6c619e700256, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Dent Mater J：WaveOne Gold Primary reciprocating锉针机械特质的评估, objectType=article, longId=168607, objectId=552316860e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552316860e6d, replyNumber=0, likeNumber=63, createdTime=2020-01-15, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552316860e6d, moduleTitle=Dent Mater J：WaveOne Gold Primary reciprocating锉针机械特质的评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=552316860e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976999, encodeId=07ed19e699963, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据, objectType=article, longId=167754, objectId=98e616e75482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98e616e75482, replyNumber=0, likeNumber=93, createdTime=2019-07-19, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98e616e75482, moduleTitle=2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=98e616e75482)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ROC

2020-05-29

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Int Immunopharmacol：Crocin通过调节巨噬细胞极化，抑制钛粒子诱导的炎症，促进种植体周围炎的再成骨

2021-06-19

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Ann Noninvasive Electrocardiol：继发性房颤更危险！中国注册研究

2021-03-01

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活

2021-02-04

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

疾病风险预测模型评价方法：ROC曲线，拟合优度检验与NRI

2021-02-28

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性

2021-04-03

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Neurocrit Care：腰穿引起的出血性休克

2020-05-18

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Circulation：高PRS的CAD患者可从alirocumab治疗中明显获益

2020-04-28

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Proc Natl Acad Sci U S A：与成年人不同，儿童使用两个大脑半球来理解执行语言功能

2020-12-08

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Eur Heart J：Alirocumab 对高龄冠心病患者预后的影响研究

2020-08-17

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Endod：重复使用Reciproc Blue在根管再治疗中的循环疲劳强度

2020-04-28

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Endod：Reciproc和Reciproc Blue系统对弯曲根管再治疗的性能比较

2020-07-16

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Endod：3种Reciprocating单支锉NiTi系统在单/双弯曲根管内的成形能力评估

2021-05-19

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

III期JADE Compare试验：JAK1抑制剂abrocitinib治疗特应性皮炎取得积极结果

2020-12-30

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Lancet：abrocitinib单药用于中重度特应性皮炎的治疗

2021-06-01

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

EMUC19：Liproca®Depot治疗前列腺癌的IIb期研究达到了主要和次要终点

2020-04-05

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Cefiderocol在治疗院内肺炎方面不逊于大剂量的美罗培南

2019-10-19

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Clin Chem：控制大麻吸入后Δ9-Tetrahydrocannabinol浓度和释放动力学的相关性

2020-07-29

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

机器学习：准确率(Precision)、召回率(Recall)、F值(F-Measure)、ROC曲线、PR曲线

2020-03-04

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Dent Mater J：WaveOne Gold Primary reciprocating锉针机械特质的评估

2020-01-15

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据

2019-07-19

科室
- - 订阅+
  - 更多科室
工具
服务